Vyndaqel Global Market Report 2025

Vyndaqel Global Market Report 2025 - By Product Type (Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg)), By Disease Type (Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Name: Vyndaqel Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Vyndaqel Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

What Is Covered Under Vyndaqel Market

Vyndaqel refers to tafamidis, a medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a heart condition caused by the buildup of misfolded transthyretin proteins. It stabilizes the transthyretin protein, preventing its misfolding and accumulation in the heart. Vyndaqel is used to reduce cardiovascular-related deaths and hospitalizations in patients with ATTR-CM. It is also prescribed to improve the quality of life for individuals suffering from this progressive and often fatal disease.

The main product types of vyndaqel are vyndaqel (tafamidis 20 mg) and vyndamax (tafamidis 61 mg). Vyndaqel (Tafamidis 20 mg) is a transthyretin stabilizer used to treat transthyretin amyloid polyneuropathy (ATTR-PN) by slowing disease progression. It is used for familial amyloid polyneuropathy (fap) and wild-type or hereditary transthyretin-mediated amyloidosis cardiomyopathy (attr-cm) and is distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

How Is The Vyndaqel Market Segmented?

The vyndaqel market covered in this report is segmented –

1) By Product Type: Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg)

2) By Disease Type: Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Vyndaqel (Tafamidis 20 mg): Oral Tablets, Oral Solution

2) By Vyndamax (Tafamidis 61 mg): Oral Capsules, Oral Suspension

Vyndaqel Market Size and growth rate 2025 to 2029: Graph

What Is The Vyndaqel Market Size 2025 And Growth Rate?

The vyndaqel market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.91 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to increasing transthyretin amyloidosis awareness, increasing prevalence of transthyretin-mediated amyloidosis cardiomyopathy, increasing focus on rare diseases, growing government support, rising clinical trials, growing geriatric population.

What Is The Vyndaqel Market Growth Forecast?

The vyndaqel market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing investment in research and developments, growing adoption of precision medicine, increasing physician familiarity, increasing availability of diagnostic tools, growing government initiatives. Major trends in the forecast period include telemedicine facility, strategic collaboration, advancements in genetic testing, digital health tools, personalized medicine.

Book your 30 minutes free consultation with our research experts

What Is Driving The Vyndaqel Market: Impact Of Increasing Investment In Research And Development On Market Growth

The increasing investment in research and development is expected to propel the growth of the vyndaqel market going forward. Research and development refers to innovating and improving products, services, or processes through systematic investigation and experimentation. The increasing investment in research and development is due to the rising prevalence of neurological disorders, advancements in medical technology, growing awareness and demand for innovative treatments, and substantial government and private sector funding initiatives. Investment in research and development accelerates the development and optimization of therapies and enhances efficacy and accessibility for patients. It drives advancements in vyndaqel, improving its effectiveness, accessibility, and potential for expanded indications. For instance, in July 2024, according to the Department of Health and Social Care, a UK-based government department, the business enterprise sector in the UK conducted pharmaceutical research and development amounting to approximately $11.1 billion in 2922, representing 0.36% of the nation’s gross domestic product. Therefore, the increasing investment in research and development is driving the growth of the vyndaqel market.

Vyndaqel Market Driver: Rising Adoption Of Precision Medicine Driving Growth In The Market

The growing adoption of precision medicine is expected to propel the growth of the vyndaqel market going forward. Personalized medicine refers to tailoring medical treatment to individual patients based on their genetic, environmental, and lifestyle factors. The adoption of personalized medicine is growing due to advancements in genomic research, improved treatment efficacy, and the rising prevalence of chronic diseases. The adoption of personalized medicine positively impacts Vyndaqel by enabling more precise diagnosis and targeted treatment for transthyretin amyloidosis (ATTR), ensuring that patients who will benefit most from the drug receive it. This approach enhances treatment efficacy, improves patient outcomes, and supports market growth by increasing the demand for specialized therapies such as Vyndaqel. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Therefore, the growing adoption of precision medicine is driving the growth of the vyndaqel market.

Vyndaqel Market Driver: Facility Expansions Driving Growth In The Market

Major companies operating in the vyndaqel market is focusing on facility expansions to produce active pharmaceutical ingredients. Facility expansion refers to the process of increasing the physical infrastructure, production capacity, or operational capabilities of a business to accommodate growth, improve efficiency, or meet rising demand. For instance, in July 2024, Pfizer Inc., a US-based pharmaceutical company manufacturing vyndaqel, opened a $1 billion plant in Singapore's Tuas Biomedical Park. Pfizer's new 429,000 sq ft facility in Tuas Biomedical Park will manufacture active pharmaceutical ingredients (APIs) for its cancer, pain, and antibiotic medicines. As an extension of Pfizer's existing site, which has been operating for 20 years, the plant is set to create 250 highly skilled jobs. The facility is recognized with a Green Mark Gold certification for its environmental sustainability efforts and aligns with Pfizer's commitment to achieving net-zero emissions by 2040.

Who Are The Major Players In The Global Vyndaqel Market?

Major companies operating in the vyndaqel market are Pfizer Inc.

What Is The Regional Outlook For The Global Vyndaqel Market?

North America was the largest region in the vyndaqel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vyndaqel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vyndaqel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vyndaqel Market?

The vyndaqel market consists of sales of cardiovascular medications, neuropathy medications, anticoagulants and diuretics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Vyndaqel Industry?

The vyndaqel market research report is one of a series of new reports from The Business Research Company that provides vyndaqel market statistics, including vyndaqel industry global market size, regional shares, competitors with a vyndaqel market share, detailed vyndaqel market segments, market trends and opportunities, and any further data you may need to thrive in the vyndaqel industry. This vyndaqel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vyndaqel Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.91 billion
Revenue Forecast In 2034	$3.67 billion
Growth Rate	CAGR of 17.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The vyndaqel market covered in this report is segmented – 1) By Product Type: Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg) 2) By Disease Type: Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM) 3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies Subsegments: 1) By Vyndaqel (Tafamidis 20 mg): Oral Tablets, Oral Solution 2) By Vyndamax (Tafamidis 61 mg): Oral Capsules, Oral Suspension
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Vyndaqel Market Characteristics

3. Vyndaqel Market Trends And Strategies

4. Vyndaqel Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vyndaqel Growth Analysis And Strategic Analysis Framework

5.1. Global Vyndaqel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Vyndaqel Market Growth Rate Analysis

5.4. Global Vyndaqel Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Vyndaqel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Vyndaqel Total Addressable Market (TAM)

6. Vyndaqel Market Segmentation

6.1. Global Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vyndaqel (Tafamidis 20 mg)

Vyndamax (Tafamidis 61 mg)

6.2. Global Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Familial Amyloid Polyneuropathy (FAP)

Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)

6.3. Global Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

6.4. Global Vyndaqel Market, Sub-Segmentation Of Vyndaqel (Tafamidis 20 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

Oral Solution

6.5. Global Vyndaqel Market, Sub-Segmentation Of Vyndamax (Tafamidis 61 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Capsules

Oral Suspension

7. Vyndaqel Market Regional And Country Analysis

7.1. Global Vyndaqel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Vyndaqel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vyndaqel Market

8.1. Asia-Pacific Vyndaqel Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vyndaqel Market

9.1. China Vyndaqel Market Overview

9.2. China Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vyndaqel Market

10.1. India Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vyndaqel Market

11.1. Japan Vyndaqel Market Overview

11.2. Japan Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vyndaqel Market

12.1. Australia Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vyndaqel Market

13.1. Indonesia Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vyndaqel Market

14.1. South Korea Vyndaqel Market Overview

14.2. South Korea Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vyndaqel Market

15.1. Western Europe Vyndaqel Market Overview

15.2. Western Europe Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vyndaqel Market

16.1. UK Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vyndaqel Market

17.1. Germany Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vyndaqel Market

18.1. France Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vyndaqel Market

19.1. Italy Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vyndaqel Market

20.1. Spain Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vyndaqel Market

21.1. Eastern Europe Vyndaqel Market Overview

21.2. Eastern Europe Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vyndaqel Market

22.1. Russia Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vyndaqel Market

23.1. North America Vyndaqel Market Overview

23.2. North America Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vyndaqel Market

24.1. USA Vyndaqel Market Overview

24.2. USA Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vyndaqel Market

25.1. Canada Vyndaqel Market Overview

25.2. Canada Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vyndaqel Market

26.1. South America Vyndaqel Market Overview

26.2. South America Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vyndaqel Market

27.1. Brazil Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vyndaqel Market

28.1. Middle East Vyndaqel Market Overview

28.2. Middle East Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vyndaqel Market

29.1. Africa Vyndaqel Market Overview

29.2. Africa Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vyndaqel Market Competitive Landscape And Company Profiles

30.1. Vyndaqel Market Competitive Landscape

30.2. Vyndaqel Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Global Vyndaqel Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Vyndaqel Market

33. Recent Developments In The Vyndaqel Market

34. Vyndaqel Market High Potential Countries, Segments and Strategies

34.1 Vyndaqel Market In 2029 - Countries Offering Most New Opportunities

34.2 Vyndaqel Market In 2029 - Segments Offering Most New Opportunities

34.3 Vyndaqel Market In 2029 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Vyndaqel Market, Sub-Segmentation Of Vyndaqel (Tafamidis 20 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Vyndaqel Market, Sub-Segmentation Of Vyndamax (Tafamidis 61 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Vyndaqel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Vyndaqel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Pfizer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Vyndaqel Market, Sub-Segmentation Of Vyndaqel (Tafamidis 20 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Vyndaqel Market, Sub-Segmentation Of Vyndamax (Tafamidis 61 mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Vyndaqel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Vyndaqel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Vyndaqel Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Vyndaqel Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Vyndaqel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Pfizer Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Global Cancer Immunotherapy Market Overview And Prospects – Includes Cancer Immunotherapy Market Share

How Will The Biosimilar Interleukins Market Grow In 2022?

Latest Cancer Clinical Decision Tools Market Growth Study 2022-2026 By The Business Research Company

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Anti-Money Laundering Global Market Report 2025 – By Product (Compliance Management, Currency Transaction Reporting, Customer Identity Management, Transaction Monitoring.), By Component (Software, Services. ), By Deployment (Cloud, On-Premise), By Organization size (Small and Medium Enterprises (SMEs), Large Enterprises), By End-User (BFSI, Government, Healthcare, IT and Telecom, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Salt Content Reduction Ingredients Global Market Report 2025 – By Product Type (Yeast Extracts, Glutamates, High Nucleotide Ingredients, Hydrolyzed Vegetable Protein, Mineral Salts, Other Product Types), By Ingredient (Mineral Blends, Amino Acid, Yeast Extract, Other Ingredients), By Application (Dairy Products, Bakery Products, Fish Derivatives, Meat And Poultry, Beverages, Sauces And Seasonings, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Laryngeal Mask Global Market Report 2025 – By Type (Reusable laryngeal masks, Disposable laryngeal masks), By Patient (Children, Adult, Geriatric), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stationary Catalytic Systems Global Market Report 2025 – By Technology (Selective Catalytic Reduction, Oxidation Catalyst), By Pollutant Type (Nox (Nitrogen Oxides), CO (Carbon Monoxide) Hydrocarbons, HAP (Hazardous Air Pollutants), DPM (Diesel Particulate Matter), NH3 (Ammonia)), By End-Use Industry (Chemical, Oil And Natural Gas, Power Plant, Metal And Mining, Cement, Other End-Use Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Event Management Software Global Market Report 2025 – By Component (Software, Services), By Deployment Type (On-premise, Cloud), By Organization Size (Small, Medium, Large), By End-User (Corporate, Government, Third-Party Planners, Education, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hydrogen Peroxide Global Market Report 2025 – By Function (Bleaching, Oxidizing, Sterilizing/Disinfecting, Propulsion, Other Functions), By Grade (Standard, Chemical, Cosmetic, Aseptic, Food, Semiconductor), By End-Use Industry (Pulp And Paper, Chemical Synthesis, Healthcare And Personal Care, Food Processing, Textile, Water And Wastewater Treatment, Electronics And Semiconductor, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Winglets Global Market Report 2025 – By Winglet Type (Sharklets, Split Scimitar Winglets, Wingtip Fences, Blended Winglets, Other Winglet Types), By Fit (Line Fit, Retrofit), By End Use (Civil Aircraft, Military Aircraft, Commercial And Cargo Aircraft) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Vyndaqel market?

How will the Vyndaqel market drivers and restraints affect the market dynamics? What forces will shape the Vyndaqel industry going forward?

The Vyndaqel market major growth driver - Impact Of Increasing Investment In Research And Development On Market Growth. For further insights on the Vyndaqel market, request a sample here

What is the forecast market size or the forecast market value of the Vyndaqel market?

The Vyndaqel market size has grown strongly in recent years. The vyndaqel market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.91 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to increasing transthyretin amyloidosis awareness, increasing prevalence of transthyretin-mediated amyloidosis cardiomyopathy, increasing focus on rare diseases, growing government support, rising clinical trials, growing geriatric population. The vyndaqel market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing investment in research and developments, growing adoption of precision medicine, increasing physician familiarity, increasing availability of diagnostic tools, growing government initiatives. Major trends in the forecast period include telemedicine facility, strategic collaboration, advancements in genetic testing, digital health tools, personalized medicine. For further insights on the Vyndaqel market, request a sample here

How is the Vyndaqel market segmented?

The vyndaqel market covered in this report is segmented –
1) By Product Type: Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg)
2) By Disease Type: Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:
1) By Vyndaqel (Tafamidis 20 mg): Oral Tablets, Oral Solution
2) By Vyndamax (Tafamidis 61 mg): Oral Capsules, Oral Suspension For further insights on the Vyndaqel market, request a sample here

Which region has the largest share of the Vyndaqel market? What are the other regions covered in the report?

Who are the major players in the Vyndaqel market?

Major companies operating in the vyndaqel market are Pfizer Inc. . For further insights on the Vyndaqel market, request a sample here.

What are the key trends in the Vyndaqel market?

Major trends in the Vyndaqel market include . For further insights on the Vyndaqel market, request a sample here.

What are the major opportunities in the Vyndaqel market? What are the strategies for the Vyndaqel market?

For detailed insights on the major opportunities and strategies in the Vyndaqel market, request a sample here.

How does the Vyndaqel market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Vyndaqel market growth and SWOT analysis of the Vyndaqel industry, request a sample here.

For detailed insights on Vyndaqel's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Vyndaqel industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Vyndaqel industry,

What are the key dynamics influencing the Vyndaqel market growth? SWOT analysis of the Vyndaqel market. request a sample here.